Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides

Diabetologia

Volumn 45, Issue 2, 2002, Pages 262-267

  Chavakis, E ^a   Riecke, B ^a   Lin, J ^a   Linn, T ^a   Bretzel, R G ^a   Preissner, K T ^a   Brownlee, M ^b   Hammes, H P ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Alphav type integrins; Basic fibroblast growth factor; Endothelial proliferation; Microvessels; Retinopathy; Vascular endothelial growth factor

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INTEGRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; RETINA NEOVASCULARIZATION;

ANIMALS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; INTEGRINS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PLATELET AGGREGATION INHIBITORS; RETINAL VESSELS;

EID: 0036189606     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0727-z     Document Type: Conference Paper

References (30)

1. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
2. Mechanisms of angiogenesis
3. Angiogenesis in cancer, vascular, rheumatoid and other disease
4. Current concepts in ophthalmology. Retinal vascular diseases
5. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
6. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
7. Requirement of vascular integrin alpha v beta 3 for angiogenesis
8. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization
9. New perspectives in cell adhesion: RGD and integrins
10. Carbohydrate derivatives for use in drug design: Cyclic alpha(v)-selective RGD peptides
11. Arg-Gly-Asp constrained within cyclic pentapeptides: Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1
12. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins
13. Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin avb3 antagonists
14. Cross talk between alpha(v)beta3 and alpha4beta1 integrins regulates lymphocyte migration on vascular cell adhesion molecule 1
15. Oxygen-induced retinopathy in the mouse
16. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: Invalidity of the antibodies for tumor angiogenesis
17. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina
18. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
19. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability
20. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
21. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
22. Coordinate expression of vascular endothelial growth factor receptor 1 (flt 1) and its ligand suggests a paracrine regulation of murine vascular development
23. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
24. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
25. Altered distribution of basic fibroblast growth factor in diabetic retinopathy
26. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells
27. Definition of two angiogenic pathways by distinct alpha v integrins
28. The extracellular matrix as a cell survival factor
29. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins
30. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy